English   español  

Browsing by Author Esteban, Mariano

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 31  next >
RightsIssue DateTitleAuthor(s)
openAccess2009Activation of NF-kB Pathway by Virus Infection Requires Rb ExpressionGarcia, Maria A.; Gallego, Pedro; Campagna, Michela; González-Santamaría, José; Esteban, Mariano; Rivas, Carmen
openAccess23-May-2013Adjuvant effect of the vaccinia virus A27 protein (14K) and the use thereof in vaccinesVijayan, Aneesh; Gómez Rodríguez, Carmen Elena; Esteban, Mariano
closedAccess2012Cryo X-ray nano-tomography of vaccinia virus infected cellsChichón, Javier; Rodríguez, María Josefa; Perdiguero, Beatriz; Esteban, Mariano; Carrascosa, José L.
closedAccess9-Jan-2008Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in PrimatesMooij, Petra; Balla-Jhagjhoorsingh, Sunita S.; Koopman, Gerrit; Beenhakker, Niels; Van Haaften, Patricia; Baak, Ilona; Nieuwenhuis, Ivonne G.; Kondova, Ivanela; Wagner, Ralf; Wolf, Hans, et al
openAccess1999Full activation of RNaseL in animal cells requires binding of 2-5A within ankyrin repeats 6 to 9 of this interferon-inducible enzymeDíaz-Guerra, Margarita; Rivas, Carmen; Esteban, Mariano
closedAccess1997Growth of Escherichia coli in acetate as a sole carbon source is inhibited by ankyrin-like repeats present in the 2′,5′-linked oligoadenylate-dependent human RNase L enzymeDíaz-Guerra, Margarita; Esteban, Mariano; Martínez, José L.
closedAccess16-Oct-2006Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1(BX08) gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade BGómez, Carmen E.; Nájera García, José Luis; Pérez Jiménez, Eva; Jiménez, Victoria; Wagner, Ralf; Graf, Marcus; Frachette, Marie-Joelle; Liljeström, Peter; Pantaleo, Giuseppe; Esteban, Mariano
openAccess14-Jan-2008An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responsesHarari, Alexandre; Bart, Pierre-Alexandre; Stöhr, Wolfgang; Tapia, Gonzalo; García Cabezas, Miguel Ángel; Medjitna-Rais, Emmanuelle; Burnet, Séverine; Cellerai, Cristina; Erlwein, Otto; Barber, Tristan, et al
openAccess2011Host-range restriction of vaccinia virus E3L deletion mutant can be overcome in vitro, but not in vivo, by expression of the influenza virus NS1 proteinGuerra, Susana; Abaitua Elustondo, Fernando; Martínez-Sobrido, L.; Esteban, Mariano; García-Sastre, A.; Rodríguez Aguirre, Dolores
openAccess1997Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replicationDíaz-Guerra, Margarita; Rivas, Carmen; Esteban, Mariano
openAccess12-Sep-2005Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a Vaccinia virus recombinantGómez, Carmen E.; Vandermeeren, Andrée M.; García López, María Ángeles; Domingo-Gil, Elena; Esteban, Mariano
openAccess26-Jul-2007Membrane cell fusion activity of the vaccinia virus A17–A27 protein complexKochan, Grazyna; Escors Murugarren, David; González, José Manuel; Casasnovas, José María; Esteban, Mariano
openAccess30-Aug-2012Method for obtaining data that can be used to evaluate, predict and/or prognosticate response to treatment with pyrimidine analoguesGarcía Chaves, María Ángel; Aguilera Gomez, Margarita; Calleja Hernandez, Miguel Angel; Marchal, Juan A.; Esteban, Mariano; Carrasco, Esther; Jiménez Gonzales, Gema; Aranega Jiménez, Antonia
openAccess3-Jan-2013Método de obtención de datos útiles para evaluar la respuesta al tratamiento con 5-fluorouracilo (5-FU)García Chaves, María Ángel; Aguilera Gomez, Margarita; Calleja Hernandez, Miguel Angel; Marchal, Juan A.; Esteban, Mariano; Carrasco, Esther; Jiménez Gonzales, Gema; Aranega Jiménez, Antonia
closedAccess29-Jul-2005Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infectionGonzález-Moro, María B.; Reina, Ramsés; García, Iker; Andrés, Sara; Glaria, Idoia; Alzueta, María; Mora, María Isabel; Pérez de la Lastra, José María; Rodríguez, Dolores; Rodriguez, Juan Ramón, et al
openAccessOct-2009P02-04. Multimeric soluble CD40 ligand efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus strainsNájera García, José Luis; Gómez, Carmen E.; Esteban, Mariano
openAccessOct-2009P17-07. Insertion of a vaccinia virus host range (hr) gene into NYVAC-B genome potentiates immune responses against HIV-1 antigensNájera García, José Luis; Gómez, Carmen E.; García-Arriaza, J.; Esteban, Mariano
openAccessOct-2009P17-23. Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitroQuakkelaar, E.; Redeker, A.; Loof, N.; Perdiguero, B.; Heinen, P.; Nieto, J.; Esteban, Mariano; Kibler, K.; Jacobs, B.; Pantaleo, Giuseppe, et al
openAccess15-Mar-2010A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary historyGonzález, José Manuel; Esteban, Mariano
openAccess24-Jan-2013Recombinant vectors based on the modified vaccinia anjara (MVA) virus, with deletion in the C6L gene, as vaccines against HIV/AIDS and other diseasesGarcía-Arriaza, J.; Gómez Rodríguez, Carmen Elena; Esteban, Mariano